These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11302934)

  • 1. Biodistribution of 4-[(14)C]cholesterol-AmBisome following a single intravenous administration to rats.
    Townsend RW; Zutshi A; Bekersky I
    Drug Metab Dispos; 2001 May; 29(5):681-5. PubMed ID: 11302934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of amphotericin B in the isolated perfused rat liver.
    Hong Y; Ramzan I; McLachlan AJ
    J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): a 91-day study in rats.
    Bekersky I; Boswell GW; Hiles R; Fielding RM; Buell D; Walsh TJ
    Pharm Res; 2000 Dec; 17(12):1494-502. PubMed ID: 11303959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, excretion, and mass balance of 14C after administration of 14C-cholesterol-labeled AmBisome to healthy volunteers.
    Bekersky I; Fielding RM; Dressler DE; Kline S; Buell DN; Walsh TJ
    J Clin Pharmacol; 2001 Sep; 41(9):963-71. PubMed ID: 11549101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats.
    Roumi M; Marleau S; du Souich P; Maggi T; Deghenghi R; Ong H
    Drug Metab Dispos; 2000 Jan; 28(1):44-50. PubMed ID: 10611139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics characterization of liposomal amphotericin B: investigation of clearance process and drug interaction potential.
    Matsui S; Imai S; Yabuki M; Komuro S
    Arzneimittelforschung; 2009; 59(9):461-70. PubMed ID: 19856794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B in rats.
    Boswell GW; Bekersky I; Buell D; Hiles R; Walsh TJ
    Antimicrob Agents Chemother; 1998 Feb; 42(2):263-8. PubMed ID: 9527770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation.
    Gershkovich P; Wasan EK; Lin M; Sivak O; Leon CG; Clement JG; Wasan KM
    J Antimicrob Chemother; 2009 Jul; 64(1):101-8. PubMed ID: 19398459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):828-33. PubMed ID: 11850268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amphotericin B--bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B].
    Pleyer U; Grammer J; Pleyer JH; Kosmidis P; Friess D; Schmidt KH; Thiel HJ
    Ophthalmologe; 1995 Aug; 92(4):469-75. PubMed ID: 7549331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tissue distribution after intravenous administration of a single dose of amphotericin B cochleates, a new lipid-based delivery system.
    Segarra I; Movshin DA; Zarif L
    J Pharm Sci; 2002 Aug; 91(8):1827-37. PubMed ID: 12115810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B.
    Smith PJ; Olson JA; Constable D; Schwartz J; Proffitt RT; Adler-Moore JP
    J Antimicrob Chemother; 2007 May; 59(5):941-51. PubMed ID: 17400589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal cyclosporine. Comparison of drug and lipid carrier pharmacokinetics and biodistribution.
    Choice E; Masin D; Bally MB; Meloche M; Madden TD
    Transplantation; 1995 Nov; 60(9):1006-11. PubMed ID: 7491673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tissue penetration on AmBisome efficacy.
    Adler-Moore J; Proffitt RT
    Curr Opin Investig Drugs; 2003 Feb; 4(2):179-85. PubMed ID: 12669379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats.
    Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH
    J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosol delivery of amphotericin B desoxycholate (Fungizone) and liposomal amphotericin B (AmBisome): aerosol characteristics and in-vivo amphotericin B deposition in rats.
    Ruijgrok EJ; Vulto AG; Van Etten EW
    J Pharm Pharmacol; 2000 Jun; 52(6):619-27. PubMed ID: 10875537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicokinetics of 14C-endosulfan in male Sprague-Dawley rats following oral administration of single or repeated doses.
    Chan MP; Morisawa S; Nakayama A; Kawamoto Y; Sugimoto M; Yoneda M
    Environ Toxicol; 2005 Oct; 20(5):533-41. PubMed ID: 16161119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism, pharmacokinetics, tissue distribution, and excretion of [14C]CP-424391 in rats.
    Khojasteh-Bakht SC; O'donnell JP; Fouda HG; Potchoiba MJ
    Drug Metab Dispos; 2005 Jan; 33(1):190-9. PubMed ID: 15486077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits.
    Lee JW; Amantea MA; Francis PA; Navarro EE; Bacher J; Pizzo PA; Walsh TJ
    Antimicrob Agents Chemother; 1994 Apr; 38(4):713-8. PubMed ID: 8031034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
    Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
    Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.